{
  "id": 14757056,
  "title": "Revolution Medicines' Pancreatic Cancer Drug Gets Positive EU Review",
  "url": "https://urgent.news/2026/10/15/revolution-medicines-pancreatic-cancer-drug-gets-positive-eu-review",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-15T17:28:32.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/revolution-medicines-pancreatic-cancer-drug-gets-positive-eu-review"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Revolution Medicines (RVMD) on Thursday said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for RASONQUE (daraxonrasib) to treat adults with metastatic pancreatic adenocarcinoma who have re",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}